Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.415
+0.145 (6.39%)
May 28, 2026, 3:28 PM EDT - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $434.91 million as of May 28, 2026. Its market cap has increased by 56.47% in one year.
Market Cap
434.91M
Enterprise Value
216.70M
1-Year Change
56.47%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $434.91M, a decrease of -0.10%. That is a compound annual growth rate of -0.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 408.80M | -57.20% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 411.50M |
| Prelude Therapeutics | 411.36M |
| Lexeo Therapeutics | 403.60M |
| InflaRx | 403.58M |
| Zura Bio | 399.45M |
| Enanta Pharmaceuticals | 393.43M |
| Benitec Biopharma | 393.36M |
| Century Therapeutics | 391.37M |